Periprocedural medication management

Abstract

Periprocedural medication management is one of the most common tasks performed by the perioperative provider. But as surgery has become more frequently offered to patients with several medical comorbidities and taking multiple medications, this task can be difficult. This is further made challenging due to the limited published data on many, if not most, of the available medications. This article is based on a presentation given at the 12th Annual Perioperative Medicine Summit on March 9, 2017 in Fort Lauderdale, Florida. The medications discussed in this presentation were selected by the following criteria: availability of published data (i.e. statins), commonly prescribed agents (i.e. psychiatric and neurologic medications, oral diabetes agents), controversial perioperative medications (i.e. angiotensin-converting enzyme inhibitors and angiotensin receptor blockers), and high-risk medications (i.e. immunomodulators). To avoid redundancy, medications discussed at other meeting sessions (i.e. anticoagulants, antiplatelet agents, beta-blockers, opioids, and insulin) were not included.